找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Short Stay Management of Chest Pain; Margarita Pena,Anwar Osborne,W. Frank Peacock Book 2022Latest edition The Editor(s) (if applicable) a

[復制鏈接]
樓主: Maudlin
41#
發(fā)表于 2025-3-28 14:55:30 | 只看該作者
Medical Therapy in Patients Managed in a Chest Pain Observation Unit,patients evaluated in CPUs are diagnosed with myocardial infarction (MI) (Newby et al., Am J Cardiol 85: 801–805, 2000; Farkouh et al., N Engl J Med, 339: 1882–1888, 1998). This chapter will address the role of aspirin, nitrates, anticoagulation, and beta-blockers in patients with undifferentiated chest pain managed in a CPU.
42#
發(fā)表于 2025-3-28 21:03:51 | 只看該作者
43#
發(fā)表于 2025-3-29 01:29:32 | 只看該作者
44#
發(fā)表于 2025-3-29 04:28:25 | 只看該作者
45#
發(fā)表于 2025-3-29 10:54:05 | 只看該作者
46#
發(fā)表于 2025-3-29 12:38:13 | 只看該作者
The Role of Biomarkers in Chest Pain Evaluation,matory markers to assays so specific that they can detect cardiac specific troponin levels to the nanogram level. This section discusses these and other emerging technologies and places them in the rubric for short-stay chest pain care relevant to guidelines and the most current evidence.
47#
發(fā)表于 2025-3-29 16:05:40 | 只看該作者
Risk Scoring Systems: Are They Necessary?,rdiac events, various scoring systems and decision tools have been derived and validated. Despite the widespread use of various peer reviewed tools there is ongoing debate in terms of how well these perform compared to general clinical gestalt.
48#
發(fā)表于 2025-3-29 22:30:08 | 只看該作者
Emergency Department Disposition of Patients Presenting with Chest Pain,roviders must use risk tools and objective data to discern if the patient is most safely treated as an inpatient, outpatient, or observed patient. This section will provide a framework for understanding these concepts.
49#
發(fā)表于 2025-3-30 01:59:03 | 只看該作者
Margarita Pena,Anwar Osborne,W. Frank PeacockOutlines the rationale for the establishment of a chest pain unit (CPU).Covers all medical aspects of CPU use and management.Explains treatment suitable to administer during the risk stratification pr
50#
發(fā)表于 2025-3-30 04:43:29 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學 Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學 Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-5 07:40
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復 返回頂部 返回列表
孟州市| 平舆县| 敦煌市| 福建省| 曲松县| 泰来县| 同江市| 浙江省| 额尔古纳市| 苗栗县| 黔西县| 逊克县| 乐东| 安国市| 永宁县| 榆林市| 淅川县| 东港市| 灵武市| 南开区| 高青县| 开江县| 裕民县| 株洲市| 佛坪县| 琼中| 都兰县| 沾化县| 大邑县| 大荔县| 秦皇岛市| 咸丰县| 阆中市| 浪卡子县| 尤溪县| 拉孜县| 昆明市| 柏乡县| 合川市| 岫岩| 奉新县|